EP1299048A4 - Biodegradable vehicles and delivery systems of biologically active substances - Google Patents

Biodegradable vehicles and delivery systems of biologically active substances

Info

Publication number
EP1299048A4
EP1299048A4 EP01918249A EP01918249A EP1299048A4 EP 1299048 A4 EP1299048 A4 EP 1299048A4 EP 01918249 A EP01918249 A EP 01918249A EP 01918249 A EP01918249 A EP 01918249A EP 1299048 A4 EP1299048 A4 EP 1299048A4
Authority
EP
European Patent Office
Prior art keywords
biologically active
active substances
delivery systems
biodegradable vehicles
biodegradable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01918249A
Other languages
German (de)
French (fr)
Other versions
EP1299048A1 (en
Inventor
Atul J Shukla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/605,661 external-priority patent/US6432438B1/en
Priority claimed from IN694MU2000 external-priority patent/IN189074B/en
Priority claimed from CN 00120871 external-priority patent/CN1206001C/en
Application filed by Individual filed Critical Individual
Publication of EP1299048A1 publication Critical patent/EP1299048A1/en
Publication of EP1299048A4 publication Critical patent/EP1299048A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/141—Plasticizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/10—Esters; Ether-esters
    • C08K5/11—Esters; Ether-esters of acyclic polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01918249A 2000-06-28 2001-02-26 Biodegradable vehicles and delivery systems of biologically active substances Withdrawn EP1299048A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/605,661 US6432438B1 (en) 1997-10-29 2000-06-28 Biodegradable vehicle and filler
US605661 2000-06-28
INMU069400 2000-07-25
IN694MU2000 IN189074B (en) 2000-07-25 2000-07-25
CN 00120871 CN1206001C (en) 2000-06-28 2000-08-03 Biodegradable carrier and biodegradable transfer system
CN00120871 2000-08-03
PCT/US2001/006138 WO2002000137A1 (en) 2000-06-28 2001-02-26 Biodegradable vehicles and delivery systems of biologically active substances

Publications (2)

Publication Number Publication Date
EP1299048A1 EP1299048A1 (en) 2003-04-09
EP1299048A4 true EP1299048A4 (en) 2005-09-28

Family

ID=27178759

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01918249A Withdrawn EP1299048A4 (en) 2000-06-28 2001-02-26 Biodegradable vehicles and delivery systems of biologically active substances

Country Status (7)

Country Link
EP (1) EP1299048A4 (en)
JP (1) JP2004511431A (en)
CN (1) CN1283215C (en)
AU (1) AU2001245346A1 (en)
CA (1) CA2413157A1 (en)
NZ (1) NZ523385A (en)
WO (1) WO2002000137A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
DE60231862D1 (en) * 2001-02-23 2009-05-20 Genentech Inc ERODABLE POLYMERS FOR INJECTION
GB0116341D0 (en) * 2001-07-04 2001-08-29 Smith & Nephew Biodegradable polymer systems
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
AR039729A1 (en) 2002-06-25 2005-03-09 Alza Corp SHORT-TERM DEPOSIT FORMULATIONS
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
MXPA05001244A (en) * 2002-07-31 2005-06-08 Alza Corp Injectable multimodal polymer depot compositions and uses thereof.
CZ294328B6 (en) * 2002-08-22 2004-11-10 Pliva-Lachema A. S. Biologically degradable composition with protracted release of a biologically active substance and process for preparing thereof
RU2355385C2 (en) 2002-11-06 2009-05-20 Алза Корпорейшн Compositions of prolongedaction with controlled release
DK2526996T3 (en) 2002-12-20 2019-12-02 Xeris Pharmaceuticals Inc Formulation for intracutaneous injection
EP1628693A1 (en) * 2003-06-04 2006-03-01 Inion Ltd. Biodegradable implant and method for manufacturing one
US8815284B2 (en) 2003-06-26 2014-08-26 Psivida Us, Inc. Bioerodible sustained release drug delivery systems
CN1863557B (en) * 2003-06-26 2010-06-16 普西维达公司 In-situ gelling drug delivery system
CA2539568C (en) * 2003-09-23 2013-09-10 Orthotherapeutics, Llc Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8329203B2 (en) 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
GB0412866D0 (en) * 2004-06-09 2004-07-14 Novartis Ag Organic compounds
US20060257448A1 (en) * 2005-05-10 2006-11-16 The University Of Zurich Resorbable polymer composition, implant and method of making implant
CA2619552A1 (en) * 2005-08-18 2007-02-22 Smith & Nephew, Plc Multimodal high strength devices and composites
US8852638B2 (en) * 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US20090048667A1 (en) * 2005-11-16 2009-02-19 Tokai University Educational System Controlled Drug-Release Composition and Drug-Releasable Medical Device
AU2008240418B2 (en) 2007-04-18 2013-08-15 Smith & Nephew Plc Expansion moulding of shape memory polymers
ATE547129T1 (en) 2007-04-19 2012-03-15 Smith & Nephew Inc MULTIMODAL SHAPE MEMORY POLYMERS
EP2150288B1 (en) 2007-04-19 2011-04-13 Smith & Nephew, Inc. Graft fixation
HUE030789T2 (en) 2007-05-18 2017-06-28 Durect Corp Improved depot formulations
BRPI0811319A2 (en) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc FLUID COMPOSITION, METHOD FOR FORMATION OF A FLUID COMPOSITION, BIODEGRADABLE IMPLANT FORMED IN SITU, METHOD FOR FORMATION OF A BIODEGRADABLE IMPLANT, KIT, IMPLANT AND TREATMENT METHOD
US8619257B2 (en) * 2007-12-13 2013-12-31 Kimberley-Clark Worldwide, Inc. Recombinant bacteriophage for detection of nosocomial infection
WO2009080275A1 (en) * 2007-12-21 2009-07-02 Ludwig-Maximilians-Universität Extruded rod-shaped devices for controlled release of biological substances to humans and animals
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
JP2013522239A (en) * 2010-03-12 2013-06-13 サーモディクス，インコーポレイテッド Injectable drug delivery system
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
US20120046225A1 (en) 2010-07-19 2012-02-23 The Regents Of The University Of Colorado, A Body Corporate Stable glucagon formulations for the treatment of hypoglycemia
CN105853348B (en) 2011-03-10 2019-08-30 Xeris药物公司 Parenteral injection stablizing solution
WO2013036309A2 (en) * 2011-06-10 2013-03-14 Wong Vernon G Sustained release formulations for delivery of proteins to the eye and methods of preparing same
WO2013067022A1 (en) 2011-10-31 2013-05-10 Xeris Pharmaceuticals, Inc. Formulations for the treatment of diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN103830767A (en) * 2012-11-26 2014-06-04 韩冰 Sucrose acetate isobutyrate gel and application thereof
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
BR112015022023B1 (en) 2013-03-11 2022-12-06 Durect Corporation INJECTABLE CONTROLLED RELEASE COMPOSITION COMPRISING HIGH VISCOSITY LIQUID CARRIER
AU2014268434B2 (en) 2013-05-24 2018-11-22 Icon Bioscience, Inc. Use of sustained release dexamethasone in post-cataract surgery inflammation
KR102428675B1 (en) 2014-08-06 2022-08-02 엑스에리스 파머수티클스, 인크. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US20170290846A1 (en) * 2014-09-30 2017-10-12 University Of Tennessee Research Foundation In situ gelling form for long-acting drug delivery
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
AR105215A1 (en) * 2015-07-01 2017-09-13 Santen Pharmaceutical Co Ltd DEPOSIT FORMULATION CONTAINING ESTERS OF CITRUS ACID
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
US20170128632A1 (en) * 2015-11-10 2017-05-11 II William Charles McJames Device and method for controlling the release of bioactive and therapeutic agents from an implantable medical device
SG11201805138VA (en) * 2015-12-17 2018-07-30 Verita Res Pte Ltd Injectable composition and a method of treatment of the physical addiction
CN106823010A (en) * 2016-12-28 2017-06-13 四川国纳科技有限公司 The purposes of bioabsorbable polyphosphate amino acid copolymer material
US11752099B2 (en) * 2017-03-27 2023-09-12 W. L. Gore & Associates, Inc. Injectable and biodegradable polymer formulations for controlled release of bioactive agents
EP4378463A2 (en) 2017-06-02 2024-06-05 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
KR20220140711A (en) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods
CN115779142B (en) * 2022-11-18 2024-01-12 江南大学 Degradable drug-carrying coating for zinc alloy implant surface, and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537559A1 (en) * 1991-10-15 1993-04-21 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
WO1998027963A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Gel composition and methods
WO1998048859A1 (en) * 1997-04-30 1998-11-05 Guilford Pharmaceuticals Inc. Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
WO1999047073A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
WO2000024374A1 (en) * 1998-10-28 2000-05-04 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (en) * 1975-07-29 1992-05-18 Merck & Co Inc PROCESS FOR THE PREPARATION OF AN ORGANIC IMPLANT.
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
SE9100610D0 (en) * 1991-03-04 1991-03-04 Procordia Ortech Ab BIORESORBABLE MATERIAL FOR MEDICAL USE

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537559A1 (en) * 1991-10-15 1993-04-21 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
WO1998027963A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Gel composition and methods
WO1998027962A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Injectable depot gel composition and method of preparing the composition
WO1998048859A1 (en) * 1997-04-30 1998-11-05 Guilford Pharmaceuticals Inc. Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
WO1999047073A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
WO2000024374A1 (en) * 1998-10-28 2000-05-04 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
GRAHAM P D ET AL: "Phase inversion dynamics of PLGA solutions related to drug delivery", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 58, no. 2, 29 March 1999 (1999-03-29), pages 233 - 245, XP004164095, ISSN: 0168-3659 *
JARR EM ET AL: "Sustained release of lidocaine from an injectable implant system for treatment of post-operative pain", PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE BIOACTIVE MATERIALS, vol. 26, July 1999 (1999-07-01), pages 631 - 632, XP002133945, ISSN: 1022-0178 *
RADOMSKY M L ET AL: "The controlled release of ganirelix from the ATRIGEL(TM) injectable implant system", PROCEEDINGS OF THE CONTROLLED RELEASE SOCIETY 1993 UNITED STATES, no. 20, 1993, pages 458 - 459, XP009051801 *
See also references of WO0200137A1 *
SHAH N H ET AL: "A BIODEGRADABLE INJECTABLE IMPLANT FOR DELIVERING MICRO AND MACROMOLECULES USING POLY(LACTIC-CO-GLYCOLIC) ACID (PLGA) COPOLYMERS", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 27, no. 2, 1 November 1993 (1993-11-01), pages 139 - 147, XP000400402, ISSN: 0168-3659 *
SHIVELY M L ET AL: "Physico-chemical characterization of a polymeric injectable implant delivery system", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 33, no. 2, February 1995 (1995-02-01), pages 237 - 243, XP004037626, ISSN: 0168-3659 *
SINGH U V ET AL: "REDUCED TOXICITY AND ENHANCED ANTITUMOR EFFICACY OF PLUMBAGIN USING POLY (LACTIC-CO-GLYCOLIC) BIODEGRADABLE INJECTABLE IMPLANT", INDIAN JOURNAL OF PHARMACOLOGY, vol. 29, no. 3, 1997, pages 168 - 172, XP001070322, ISSN: 0253-7613 *

Also Published As

Publication number Publication date
JP2004511431A (en) 2004-04-15
WO2002000137A1 (en) 2002-01-03
CN1283215C (en) 2006-11-08
CN1438858A (en) 2003-08-27
EP1299048A1 (en) 2003-04-09
NZ523385A (en) 2005-09-30
AU2001245346A1 (en) 2002-01-08
CA2413157A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
EP1299048A4 (en) Biodegradable vehicles and delivery systems of biologically active substances
AU2001275505A1 (en) Delivery systems comprising biocompatible and bioerodable membranes
IL143087A0 (en) Drug delivery systems and methods
GB0005839D0 (en) Storage and delivery of micro-organisms
AU2001233526A1 (en) Stent delivery system and method of use
AU2001281344A1 (en) Angulated stent delivery system and method of use
AU2001288738A1 (en) Highly active metathesis catalysts generated in situ from inexpensive and air stable precursors
AU3458999A (en) Mesh stent and delivery system
HUP0104168A3 (en) Spray on bandage and drug delivery system
AU9617698A (en) Polymeric systems for drug delivery and uses thereof
AU2002231058A1 (en) Biologically active agent delivery apparatus and method
AU5154000A (en) Stabilization and acoustic activation of polymeric micelles for drug delivery
AU2003273181A8 (en) Vehicles for delivery of biologically active substances
HK1038057A1 (en) Wick-based liquid emanation system with child-resistant and miniaturization features
IL143962A0 (en) Polymeric delivery agents and delivery agent compounds
EP1019031A4 (en) Biodegradable macromers for the controlled release of biologically active substances
AU3838401A (en) Delivery systems using preformed biodegradable polymer compositions and methods
LT2000095A (en) Aerosolised active agent delivery
EP1162952A4 (en) Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
HUP0102803A3 (en) Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents
AU2001238384A1 (en) Delivery systems using preformed biodegradable polymer compositions and methods
HK1047324A1 (en) Multi-asset participation structured note and swap combination
EP1098673A4 (en) Agent delivery systems
EP1021168A4 (en) Micro-particulate and nano-particulate polymeric delivery system
EP1207812A4 (en) Implant and agent delivery device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030128

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050811

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61L 27/00 B

Ipc: 7A 61K 38/00 B

Ipc: 7A 61K 31/00 B

Ipc: 7A 61K 47/22 B

Ipc: 7A 61K 47/14 B

Ipc: 7A 61K 47/34 B

Ipc: 7A 61K 9/06 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060901